Condensed Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Operating expenses:
Research and development	$ 31,825	$ 21,938	$ 65,601	$ 46,333
General and administrative	7,073	5,719	14,356	11,355
Total operating expenses	38,898	27,657	79,957	57,688
Loss from operations	(38,898)	(27,657)	(79,957)	(57,688)
Interest and other income, net	1,622	2,766	3,620	3,746
Net loss	(37,276)	(24,891)	(76,337)	(53,942)
Other comprehensive loss:
Unrealized gain (loss) on investments, net				1
Comprehensive loss	$ (37,276)	$ (24,891)	$ (76,337)	$ (53,941)
Net loss per common share, basic	$ (1.03)	$ (0.7)	$ (2.12)	$ (1.66)
Net loss per common share, diluted	$ (1.03)	$ (0.7)	$ (2.12)	$ (1.66)
Weighted-average number of common shares used to compute basic net loss per common share	36,043,561	35,348,293	35,966,965	32,483,297
Weighted-average number of common shares used to compute diluted net loss per common share	36,043,561	35,348,293	35,966,965	32,483,297